| 物质名称 | CAS登记号 | 物质唯一标识 | 分子式 | 异名/同义词 |
|---|---|---|---|---|
| ELRANATAMAB | 2408850-14-4 | L0HR9A577V | L0HR9A577V | ANTI-CD3/ANTI-BCMA BISPECIFIC MONOCLONAL ANTIBODY PF-06863135 B-CELL MATURATION ANTIGEN (BCMA) CLUSTER OF DIFFERENTIATION 3 (CD3) BISPECIFIC MONOCLONAL ANTIBODY (MAB) ANTI-BCMA/ANTI-CD3 BISPECIFIC MAB ELRANATAMAB ELRANATAMAB [INN] ELRANATAMAB [USAN] ELRANATAMAB [WHO-DD] ELRANATAMAB BCMM [WHO-DD] ELRANATAMAB-BCMM ELREXFIO IMMUNOGLOBULIN G2 (224-ARGININE,265-ALANINE,330-SERINE,331-SERINE), ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-MUS MUSCULUS MONOCLONAL PF-06863059 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PF-06863059 .KAPPA.-CHAIN, (223->217')(227->221')(230->224')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G2 (218-GLUTAMIC ACID,259-ALANINE,324-SERINE,325-SERINE) ANTI-(HUMAN B-CELL MATURATION ANTIGEN) (HUMAN MONOCLONAL PF-06863058 .GAMMA.2-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL PF-06863058 .KAPPA.-CHAIN PF-06863135 RN613 RN-613 |